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Introduction {#sec0005}
============

Onychomycosis is a fungal infection of the nails caused by dermatophytic fungi and yeasts.[@bib0305], [@bib0310], [@bib0315], [@bib0320], [@bib0325] The main etiological agents are *Trichophyton, Epidermophyton*, and *Candida* fungi.[@bib0330], [@bib0335] Onychomycosis is an emerging global health problem, as it represents 50% of nail disorders[@bib0305], [@bib0340], [@bib0345] and affects 2--9% of the world population.[@bib0310], [@bib0350] This pathological condition affects quality of life, with loss of the patient self-esteem and may result in physical, occupational, and social limitations.[@bib0310], [@bib0355], [@bib0360]

Notable among the main factors related to onychomycosis are humidity, wearing closed shoes, repetitive nail trauma, genetic predisposition, and chronic diseases, such as diabetes, HIV, and immunosenescence.[@bib0310], [@bib0350], [@bib0365], [@bib0370], [@bib0375], [@bib0380] Moreover, the main etiological agents of onychomycosis in infected areas are *Trichophyton rubrum* (60%), *Trichophyton mentagrophytes* (20%), *Epidermophyton floccosum* (10%), and *Candida albicans* (5--10%).[@bib0305], [@bib0310], [@bib0315], [@bib0345] The *T. mentagrophytes* complex is particularly difficult to identify because of the morphological features and the inter-specific relationships within this group are unclear, requiring molecular tools to identify species in this complex.[@bib0385]

Despite recent advances in medicine, treating onychomycosis remains challenging due to the anatomical characteristics of nails and the poor efficacy of currently available treatments.[@bib0305], [@bib0390], [@bib0395], [@bib0400] Existing therapies for onychomycosis are only partially effective, and recurrence and consequent fungal resistance are common when combined with poor medication compliance.[@bib0405], [@bib0410], [@bib0415], [@bib0420], [@bib0425] Furthermore, oral antifungal drugs are associated with undesirable side effects, such as hepatotoxicity.[@bib0340], [@bib0350], [@bib0395] Therefore, new alternatives to prevent, diagnose, and treat onychomycosis are of utmost importance.[@bib0430] Thus, the discovery of novel antifungal compounds is urgently necessary to develop more effective, economical therapies with fewer side effects. Amine and amide groups are significant functional groups in medications due to their reactive and chemical properties,[@bib0435] and these groups comprise peptides found in various proteins.[@bib0440] Our previous data show that amino alcohols have antimicrobial and immunological activities against *Trypanosoma cruzi*.[@bib0445], [@bib0450], [@bib0455], [@bib0460] Thus, the present study evaluated the antifungal activities of amphiphilic aromatic amino alcohols and amides against different strains of fungi associated with onychomycosis.

Materials and methods {#sec0010}
=====================

Chemistry {#sec0015}
---------

Amino alcohols **4a--4f** were synthesized from *p*-hydroxybenzaldehyde 1, as described previously by Almeida et al. (2013) and amides **9a--9f** were synthesized from *p*-hydroxybenzoic acid **5**.[@bib0445] Briefly, compound **1** was previously *O*-alkylated and then submitted to a direct reductive amination reaction in the presence of 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris), resulting in targeted amino alcohols **4a--4f** with 32--87% yield ([Fig. 1](#fig0005){ref-type="fig"}). Amphiphilic aromatic amides **9a--9f** was obtained from *O*-alkylated esters **7a--7f** prepared from carboxylic acid **5**. After hydrolysis of the ethyl ester, the carboxyl group was converted to acyl chloride and treated with Tris, resulting in the desired amides ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 1Synthesis of the amine series adapted from Almeida et al. (2013).[@bib0445]Fig. 2Synthesis of the amide series adapted from Almeida et al. (2013).[@bib0445]

Fungal strains {#sec0020}
--------------

Experiments were conducted using *T. rubrum* CCT-5507 URM 1666 obtained from the Collection of Tropical Crops (CCT) provided by the André Tosello Foundation (Campinas, São Paulo, SP, Brazil), *T. mentagrophytes* ATCC 11481 and *C. albicans* ATCC 10231 from the American Type Culture Collection (ATCC) were provided by the National Institute of Quality Control in Health-Oswaldo Cruz Foundation (Rio de Janeiro, RJ, Brazil).

Molecular identification {#sec0025}
------------------------

Genomic DNA was extracted from *T. mentagrophytes* ATCC 11481 to identify the fungal strain complex. Partial sequencing of the internal transcribed spacer (ITS) region was evaluated using ITS1 (TCCGTAGGTGAACCTGCGG) and ITS4 (TCCTCCGCTTATTGATATGC).[@bib0465] Briefly, the conditions were 100 ng DNA, 10 pmol of each primer, and an annealing temperature of 58 °C. Automated sequencing was evaluated using the Sequencing Platform at Fundação Oswaldo Cruz-PDTIS/FIOCRUZ, Brazil. The sequences were edited using Sequencher 4.9 software and compared with BLAST. The ITS sequence isolated from *T. mentagrophytes* ATCC 11481 was deposited in Genbank under accession number NCBI/GenBank KX132909. This procedure was not necessary for other strains used herein because these standard strains have been investigated recently by different authors,[@bib0470], [@bib0475] confirming the characterization of the strains.

Antifungal activity {#sec0030}
-------------------

### Minimum inhibitory concentration (MIC) assay {#sec0035}

The experiment was conducted using broth dilution. The MIC assay was performed according to Clinical and Laboratory Standards Institute (CLSI) protocols M38-A2,[@bib0480] M27-A3,[@bib0485] and M27-S4,[@bib0490] as described previously. All analyses were performed in triplicate. A filamentous fungal suspension was prepared using 7-day cultures maintained in tubes containing Sabouraud dextrose agar (SDA) at 28 ± 2 °C, for yeast the microdilution test is incubated at 35 ± 2 °C. Then, three washes were performed by adding 2 mL of 0.85% sterile saline and 20 μL Tween-80. The suspensions were analyzed using a spectrophotometer (Libra S12; Biochrom, Cambourne, UK) and 89--90% transmittance at a wavelength of 530 nm.[@bib0495] The suspensions were diluted 1:50 (v/v) in RPMI-1640 culture medium (Sigma, St. Louis, MO, USA) buffered with 3 (N-morpholino) propanesulfonic acid (MOPS; JT Baker, Griesheim, Germany), resulting in a suspension containing 0.4--5.0 × 10^4^ CFU/mL. The *C. albicans* ATCC 10231 cultures were used after 48 h of growth in tubes with SDA at 37 ± 2 °C. The cultures were diluted and analyzed with a spectrophotometer as described above. Finally, the suspension was diluted in RPMI-1640 culture medium and buffered with MOPS to provide a suspension of 5--25 × 10^2^ CFU/mL.[@bib0485], [@bib0500]

The amphiphilic aromatic amino alcohol and amide compounds were solubilized in RPMI-1640 culture medium, buffered with MOPS, and tested for filamentous fungi at final concentrations of 7.8--1000 μg/mL and 39.06--5000 μg/mL for yeasts. Fungal growth was assessed by adding 100 μL RPMI-1640 culture medium buffered with MOPS containing the fungal inoculum. The fungi were homogenized for 2 min and incubated in a sterile 96-well plate at 28 ± 2 °C for seven days (dermatophytes) or 37 ± 2 °C for 48 h (yeasts). The fungi were analyzed visually using a SMZ800 microscope (Nikon, Melville, NY). Terbinafine, ketoconazole, and amphotericin B were used as reference drugs and assessed in accordance with the M38-A2[@bib0480] and M27-A3[@bib0485] protocols.

### Minimum fungicidal concentration (MFC) analysis {#sec0040}

The MFC of filamentous fungi was determined by plating 10 μL from wells without fungal growth to a new sterile 96-well microplate containing 200 μL of Sabouraud dextrose broth (SDB), as described previously.[@bib0505] The MFC was determined as the lowest concentration of the aromatic compound that reduced the initial fungal count \>99.9%. The MFC for *C. albicans* was evaluated using 5 μL from wells without fungal growth, which was transferred to cryotubes containing 1000 μL SDB. The analysis was conducted as described above. All experiments were performed in triplicate, and the results are presented as geometric means of the replicates.

Cell viability assay {#sec0045}
--------------------

Cytotoxic effects in J774 cells were assessed by culturing macrophages (5 × 10^5^) with different concentrations of the amine compounds (**4b--4e**) (0.1--100 μg/mL) in 96-well tissue culture plates at 37 °C in 5% CO~2~ for 48 h. Cell viability was determined by the colorimetric MTT assay \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\].[@bib0510] The cytotoxicity results were displayed as percentage of cell viability comparing with untreated cells (100% of viability). Absorbance of the solubilized MTT formazan product was spectrophotometrically measured at 540 nm using a SpectraMax 190 microplate reader (Molecular Devices, Sunnyvale, CA, USA). All samples were run in triplicate and analyzed on the same day to minimize day-to-day variation.

Results {#sec0050}
=======

The sequence obtained by partial sequencing of the ITS region (NCBI/GenBank KX132909) was isolated from ATCC 11481 and was 100% concordant with that of *T. mentagrophytes* JX122271 deposited in Genbank. The MIC and MFC values of the compounds, as well as those of terbinafine, ketoconazole, and amphotericin B, were assessed in the fungal strains *T. rubrum*, *T. mentagrophytes*, and *C. albicans* ([Table 1](#tbl0005){ref-type="table"}).Table 1*In vitro* inhibitory activity of amphiphilic aromatic amino alcohols and amides.Table 1CompoundsFungal strains*Trichophyton rubrum* CCT 5507 URM 1666*Trichophyton mentagrophytes* ATCC 11481*Candida albicans* ATCC 10231MICMFCMICMFCMICMFC**4a**62.5500125125\>5000ND**4b**62.512515.6215.6278312.5**4c**7.815.6215.6215.6231.2531.25**4d**31.2531.2531.2512562.5125**4e**15.6262.57.862.515.6515.65**4f**\>1000ND62.5125500\>5000**9a**\>1000ND\>1000ND\>5000ND**9b**\>1000ND\>1000ND\>5000ND**9c**\>1000ND\>1000ND625\>5000**9d**\>1000ND\>1000ND\>5000ND**9e**\>1000ND\>1000ND\>5000ND**9f**\>1000ND\>1000ND\>5000NDTerbinafine0.190.190.030.03NENEKetoconazole140.250.25NENEAmphotericin BNENENENE0.1250.5[^1]

As described in [Table 1](#tbl0005){ref-type="table"}, the amine series (**4b--4e**) was effective against *T. rubrum* CCT 5507 URM 1666 (MIC ≤ 62.5 μg/mL and MFC ≤ 500 μg/mL), *T. mentagrophytes* ATCC 11481 (MIC ≤ 31.25 μg/mL and MFC ≤ 125 μg/mL), and *C. albicans* ATCC 10231 (MIC ≤ 62.5 μg/mL and MFC ≤ 312.5 μg/mL). Compound **4c** almost abolished growth of *T. rubrum* CCT 5507 URM 1666 (MIC = 7.8 μg/mL and MFC = 15.62 μg/mL) and *T. mentagrophytes* ATCC 11481 (MIC = 15.62 μg/mL and MFC = 15.62 μg/mL). Notably, this effect was quite similar to that caused by terbinafine (0.03--1 μg/mL) and ketoconazole (0.25--16 μg/mL) ([Table 1](#tbl0005){ref-type="table"}), which were the clinical antifungal reference drugs ([Table 1](#tbl0005){ref-type="table"}). Moreover, compounds **4a** and **4f** moderately inhibited growth of *T. rubrum* and *T. mentagrophytes*, suggesting that antifungal activity may be related to the number of carbon atoms (8C--12C) in the aliphatic chain. Nevertheless, amides **9a--9f** failed to inhibit any of the filamentous fungal or yeast strains ([Table 1](#tbl0005){ref-type="table"}), except amide **9c**, which demonstrated activity against *C. albicans* ATCC 10231 (fungistatic at 625 μg/mL). Amphotericin B, which is used clinically, inhibited growth of *C. albicans* (MIC = 0.125 μg/mL and MFC = 0.5 μg/mL) ([Table 1](#tbl0005){ref-type="table"}).

Aiming to rule out the possibility of cytotoxic activity of compounds **4b--4e**, we accessed in another set of experiments the amine molecules on macrophages J774. Results depicted in [Fig. 3](#fig0015){ref-type="fig"} show that compounds **4b--4d** at 0.1--10 μg/mL displayed lower cytotoxic effect on macrophage (cell viability more than 80%). The compound **4e** decreased the viability of macrophages by 44.1%, 44.4% and 49.9% at the concentration 0.1, 1 and 10 μg/mL, respectively ([Fig. 3](#fig0015){ref-type="fig"}). All compounds **4b--4e** reduced significantly the cell viability only at the concentration of 50 and 100 μg/mL.Fig. 3*In vitro* cell viability assay of compounds **4b--4e** on J774 macrophages.

Discussion {#sec0055}
==========

We identified a new partial sequence in the ITS region from the *T. mentagrophytes* ATCC 11481-NCBI/GenBank KX132909 complex due to the difficulties of identifying different species using only phenotypic characteristics, as reported previously by Packeu et al. (2013).[@bib0515] Moreover, this procedure was not necessary for other strains used herein because these standard strains have been investigated recently by different authors,[@bib0390], [@bib0470], [@bib0520], [@bib0525] confirming the characterization of the strains.

Importantly, the amphiphilic character of the organic compounds reflects their ability to interact and penetrate biological membranes inducing different effects,[@bib0445], [@bib0460], [@bib0530] such as increased antimicrobial activity.[@bib0535] Lipophilicity is an important characteristic of antifungal agents, such as terbinafine and ketoconazole, and is also evident in drugs like amphotericin B, which have proven effectiveness to treat systemic fungal infections.[@bib0530] The relevance of the lipophilic chain in amino alcohols was reported by Almeida et al. (2013),[@bib0445] who assessed antibacterial activity on some bacterial strains, such as *Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis*, and methicillin-resistant *S. aureus*, demonstrating that lipophilic compounds show potent antimicrobial activities. In this study, we extended and added to these findings by demonstrating that amino alcohols **4b--4e** showed significant antifungal activity, although lipophilic compound **4a** and the most lipophilic amino alcohol **4f** only displayed antifungal activity against two of the fungal strains tested.

The evaluation of the structure--activity relationships of amines showed that increasing the number of carbons in the aliphatic chain to eight favored antifungal action, corroborating and extending previously published data.[@bib0540]

This reduction in antifungal potential can be associated with size of the carbonic side chains 3C and 13C for **4a** and **4f** compounds, respectively. The results obtained with compound **4e** contradict that higher lipophilicity of the compound permits penetration into the target cell and consequently its pharmacological action, as reported by Gushchina et al. (2015).[@bib0545] However, this hypothesis was confirmed by Almeida et al. (2013),[@bib0445] who demonstrated the same profile with amino alcohol compounds, which show less antibacterial action as the carbon chain is elongated. Dolezal et al. (2002) reported marked activity against *Clorella vulgaris* after associating lipophilicity with its alkoxy substituent.[@bib0550] Smolarz et al. (2005) discovered that the antifungal potential of 2-carboxy-3,5-dimethoxy-E-stilbene against *Trichophyton* spp. strains is related to the same physicochemical characteristics reported above.[@bib0555] Although amides are found in different pharmaceutical compounds,[@bib0560], [@bib0565] compounds **9a--9f** did not significantly inhibit growth of filamentous fungi or yeast, except compound **9c**, which has an alkyl chain bearing eight carbon atoms.

The discrepancy between the antifungal activities of amino alcohols **4a--4f** and those of amides **9a--9f** suggests that amine groups could contribute to antifungal action, as only amine compounds are in a hydrochloride form, which helps with their water solubility and absorption. Shah et al. (2015) observed similar results when they assessed amine and amide compounds toxic to *C. albicans*.[@bib0570] Thus, antifungal potential is related to the size of the lateral aliphatic chain and can directly improve efficacy.[@bib0575] Surprisingly, our data suggest that intermediate size aliphatic amine chains showed a notable effect, justifying additional experiments.

Previous studies have reported a direct correlation between *in vitro* cytotoxicity and *in vivo* acute toxicity in animals and humans[@bib0580]; therefore, investigating the toxicological effects of new antifungal compounds in normal cells are important. Herein, the cytotoxicity of compounds **4b--4e** was evaluated using an MTT assay with macrophages. Compound **4e** decreased viability of macrophages by 44.1%, 44.4%, and 49.9% at concentrations of 0.1, 1, and 10 μg/mL, respectively. Our data also show that compounds **4b--4e** reduced cell viability only at 50 and 100 μg/mL, indicating that higher concentrations reduced macrophage viability and fungal growth. These results suggest that less toxicity was associated with the presence of an intermediate number of carbons in the side chain, as compounds with eight carbons in the aliphatic chain were more cytotoxic than those with 7, 9, or 11 carbons. Thus, additional *in vitro* cytotoxic assays should be conducted to determine the safety profile of any potential drug candidate for therapeutic applications in animals and humans.

According to the World Health Organization (WHO), resistant microorganisms (including bacteria, fungi, viruses, and parasites) can withstand attack by antimicrobial drugs, so standard treatments can become ineffective and infections persist, increasing the risk of spread to other microbes, resulting in resistance.[@bib0585] The 2014 WHO report on global surveillance of antimicrobial resistance revealed that antimicrobial resistance, including antifungal resistance, is no longer a prediction for the future, as it is occurring worldwide now and is increasing the risk of being unable to properly treat common infections in the community and hospitals. For this reason, fostering innovative research and developing new vaccines, diagnostics, infection treatment options, and other tools is urgently needed.[@bib0410], [@bib0590], [@bib0595], [@bib0600]

In summary, the data presented here demonstrate that amphiphilic aromatic amino alcohols (**4b**--**4e**) markedly inhibited standard strains of fungi, such as *T. rubrum*, *T. mentagrophytes* and *C. albicans*. Although these compounds have presented cytotoxic effect on macrophages; they might constitute potential as leader molecules in the development of innovative antifungal (aiming effectiveness and safety) for the treatment of fungal infection, including onychomycosis.

Conflicts of interest {#sec0060}
=====================

No conflict of interest was declared.

This research was supported by CAPES, CNPq, FAPEMIG, and PROPESQ/UFJF.

[^1]: ND, not determined (MIC \>1000 μg/mL or MIC \>5000 μg/mL); NE, not evaluated; MIC, minimum inhibitory concentration; MFC, minimum fungicidal concentration. Results are expressed as μg/mL.
